Investigation of the Quantity of Exhaled Aerosols Released into the Environment during Nebulisation
Background: Secondary inhalation of medical aerosols is a significant occupational hazard in both clinical and homecare settings. Exposure to fugitive emissions generated during aerosol therapy increases the risk of the unnecessary inhalation of medication, as well as toxic side effects. Methods: Th...
Main Authors: | James A. McGrath, Andrew O’Sullivan, Gavin Bennett, Ciarraí O’Toole, Mary Joyce, Miriam A. Byrne, Ronan MacLoughlin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/2/75 |
Similar Items
-
Evaluation of Aerosol Therapy during the Escalation of Care in a Model of Adult Cystic Fibrosis
by: Elena Fernández Fernández, et al.
Published: (2021-04-01) -
Evaluation of Aerosol Drug Delivery Options during Adult Mechanical Ventilation in the COVID-19 Era
by: Piers J. Naughton, et al.
Published: (2021-09-01) -
Nebuliser Type Influences Both Patient-Derived Bioaerosol Emissions and Ventilation Parameters during Mechanical Ventilation
by: Mary Joyce, et al.
Published: (2021-02-01) -
Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19
by: Waiting Tai, et al.
Published: (2021-08-01) -
An in vitro study of the effects of respiratory circuit setup and parameters on aerosol delivery during mechanical ventilation
by: Leanne Reilly, et al.
Published: (2024-01-01)